Business Visionary and Strategist || Founder || Investor || Advisor to Health Tech Startups || Expert in SDOH, Meaningful Use of Data, Scalability, Reliability & In-Home Medical Care || Advocate for Healthcare Equity
AI powered healthcare technology is garnering significant interest in implementation. As it evolves, so are the regulations around it. Recently, the FDA announced clearance for AliveCor’s AI technology in cardiology. The technology can predict cardiac conditions, including heart attacks with a reduced lead set. Simultaneously, the FDA also granted approval for AliveCor’s handheld ECG model. The model uses a single cable system, is lightweight, and easy to use for medical professionals. It is now also clinically proven. The FDA’s approval of this new technology is important, not only because it helps get life-saving technology in the hands of physicians, but because it is an essential part of determining the future of regulation. As new healthcare technology involving AI is introduced for FDA approval, the agency will look to past cases. The boundaries they set will determine what technology can get into the hands of people who need it most. #FDA #MedicalTechnology #AI
